Allianz Asset Management Gmb H Alnylam Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

  • $74.9 Billion
  • Q2 2025

A detailed history of Allianz Asset Management Gmb H transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 205,993 shares of ALNY stock, worth $99.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
205,993
Previous 218,503 5.73%
Holding current value
$99.1 Million
Previous $59 Million 13.85%
% of portfolio
0.09%
Previous 0.08%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025
SELL
$224.32 - $326.09 $2.81 Million - $4.08 Million
-12,510 Reduced 5.73%
205,993 $67.2 Million
Q1 2025

May 05, 2025
BUY
$233.07 - $290.7 $25.6 Million - $31.9 Million
109,632 Added 100.7%
218,503 $59 Million
Q4 2024

Feb 03, 2025
BUY
$232.27 - $300.43 $19.1 Million - $24.7 Million
82,065 Added 306.14%
108,871 $25.6 Million
Q3 2024

Nov 12, 2024
BUY
$233.81 - $287.01 $2.02 Million - $2.48 Million
8,632 Added 47.5%
26,806 $7.37 Million
Q2 2024

Aug 13, 2024
BUY
$143.31 - $247.0 $954,444 - $1.65 Million
6,660 Added 57.84%
18,174 $4.42 Million
Q1 2024

May 13, 2024
SELL
$146.51 - $198.2 $333,310 - $450,905
-2,275 Reduced 16.5%
11,514 $1.72 Million
Q4 2023

Feb 12, 2024
SELL
$151.41 - $196.57 $100,233 - $130,129
-662 Reduced 4.58%
13,789 $2.64 Million
Q3 2023

Nov 13, 2023
SELL
$170.77 - $211.65 $366,130 - $453,777
-2,144 Reduced 12.92%
14,451 $2.56 Million
Q2 2023

Aug 11, 2023
SELL
$185.01 - $212.05 $379,640 - $435,126
-2,052 Reduced 11.0%
16,595 $3.15 Million
Q1 2023

May 11, 2023
BUY
$182.66 - $235.53 $53,702 - $69,245
294 Added 1.6%
18,647 $3.74 Million
Q4 2022

Feb 13, 2023
SELL
$185.53 - $241.31 $628,946 - $818,040
-3,390 Reduced 15.59%
18,353 $4.36 Million
Q3 2022

Nov 08, 2022
SELL
$138.54 - $232.0 $3.87 Million - $6.49 Million
-27,968 Reduced 56.26%
21,743 $4.35 Million
Q2 2022

Aug 12, 2022
BUY
$120.42 - $169.29 $575,968 - $809,714
4,783 Added 10.65%
49,711 $7.25 Million
Q1 2022

May 13, 2022
SELL
$127.18 - $173.91 $780,376 - $1.07 Million
-6,136 Reduced 12.02%
44,928 $7.34 Million
Q4 2021

Feb 11, 2022
SELL
$159.56 - $209.29 $716,424 - $939,712
-4,490 Reduced 8.08%
51,064 $8.67 Million
Q3 2021

Nov 10, 2021
BUY
$169.75 - $207.73 $3.56 Million - $4.35 Million
20,955 Added 60.57%
55,554 $10.5 Million
Q2 2021

Aug 16, 2021
SELL
$128.63 - $176.89 $367,881 - $505,905
-2,860 Reduced 7.64%
34,599 $5.87 Million
Q1 2021

May 13, 2021
BUY
$126.83 - $175.69 $944,249 - $1.31 Million
7,445 Added 24.81%
37,459 $5.29 Million
Q4 2020

Feb 16, 2021
SELL
$122.97 - $147.0 $196,137 - $234,465
-1,595 Reduced 5.05%
30,014 $3.9 Million
Q3 2020

Nov 13, 2020
SELL
$121.19 - $165.49 $848,572 - $1.16 Million
-7,002 Reduced 18.13%
31,609 $4.6 Million
Q2 2020

Aug 14, 2020
SELL
$104.21 - $156.44 $543,350 - $815,678
-5,214 Reduced 11.9%
38,611 $5.72 Million
Q1 2020

May 14, 2020
SELL
$93.12 - $133.99 $1.39 Million - $1.99 Million
-14,881 Reduced 25.35%
43,825 $4.77 Million
Q4 2019

Feb 13, 2020
SELL
$74.51 - $124.23 $2.18 Million - $3.63 Million
-29,211 Reduced 33.23%
58,706 $6.76 Million
Q3 2019

Nov 13, 2019
SELL
$70.9 - $87.82 $1.19 Million - $1.47 Million
-16,736 Reduced 15.99%
87,917 $7.09 Million
Q2 2019

Aug 08, 2019
SELL
$65.86 - $92.79 $1.27 Million - $1.79 Million
-19,274 Reduced 15.55%
104,653 $7.59 Million
Q1 2019

May 13, 2019
SELL
$72.76 - $93.45 $1.74 Million - $2.23 Million
-23,886 Reduced 16.16%
123,927 $11.6 Million
Q4 2018

Feb 14, 2019
SELL
$62.67 - $88.33 $1.67 Million - $2.35 Million
-26,637 Reduced 15.27%
147,813 $10.7 Million
Q3 2018

Nov 13, 2018
BUY
$87.52 - $122.67 $3.39 Million - $4.75 Million
38,720 Added 28.53%
174,450 $15.3 Million
Q2 2018

Aug 13, 2018
BUY
$88.31 - $107.8 $5.65 Million - $6.9 Million
63,975 Added 89.16%
135,730 $13.4 Million
Q1 2018

May 14, 2018
BUY
$115.92 - $148.54 $11,592 - $14,854
100 Added 0.14%
71,755 $8.55 Million
Q4 2017

Feb 13, 2018
BUY
$114.49 - $139.98 $5.11 Million - $6.25 Million
44,655 Added 165.39%
71,655 $9.1 Million
Q3 2017

Nov 13, 2017
SELL
$72.53 - $118.27 $230,427 - $375,743
-3,177 Reduced 10.53%
27,000 $3.17 Million
Q2 2017

Aug 14, 2017
BUY
N/A
3,177 Added 11.77%
30,177 $2.39 Million
Q4 2016

Apr 17, 2019
SELL
N/A
-63,574 Reduced 70.19%
27,000 $1.01 Million
Q3 2016

Apr 17, 2019
BUY
N/A
90,574
90,574 $6.3 Million

Others Institutions Holding ALNY

# of Institutions
763
Shares Held
115M
Call Options Held
584K
Put Options Held
661K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $59.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email